Filing Flows › Orthofix Medical (OFIX) › Q1 FY25
Orthofix Medical (OFIX) Q1 FY25 earnings results (first quarter fiscal 2025)
10-Q filed May 6, 2025
Orthofix Medical (OFIX) reported revenue of $194M for the first quarter fiscal 2025 (Q1 FY25), +3% from a year earlier and -10% from the quarter before. Operating margin was -25.2%, net loss $53.1M (27.4% of revenue).
Orthofix Medical, Q1 FY25: revenue $194M (+3% year over year), operating margin -25.2%, net loss $53.1M, operating cash flow −$18.4M. The chart follows the revenue to costs, profit and cash.
| Q1 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $194M | -10% | +3% |
| Operating profit | −$48.9M | — | — |
| Net earnings | −$53.1M | — | — |
| Operating cash flow | −$18.4M | -178% | — |
What changed
Revenue was $193.6M in Q1 FY25, up 3% year over year and down 10% from the previous quarter. Global Spine was the largest line at 85% of revenue. Global Spine added $2.5M year over year (up 2%), 50% of the total change.
Gross margin was 62.8%, down 4.7 points from a year earlier. Operating costs exceeded revenue by $48.9M, an operating margin of -25.2%. Operating expenses grew 9% against revenue growth of 3%. The fastest-growing cost line was Other operating costs (+229%). The quarter ended with a net loss of $53.1M, wider than the previous quarter's $29.1M loss.
Operating cash flow was −$18.4M. Non-cash charges added back $34.4M of depreciation and amortization and $6.5M of share-based compensation. Working capital and other items used $6.2M. Capital expenditures of $6.7M exceeded it, leaving free cash flow of −$25.1M.
Questions
What was Orthofix Medical's revenue in the first quarter fiscal 2025?
Orthofix Medical (OFIX) reported revenue of $194M for the first quarter fiscal 2025 (Q1 FY25), +3% from a year earlier and -10% from the quarter before.
Was Orthofix Medical profitable in the first quarter fiscal 2025?
Operating loss was $48.9M (-25.2% of revenue) and net loss $53.1M.
Source: Orthofix Medical 10-Q on SEC EDGAR.